Tethering transforming growth factor β1 to soft hydrogels guides vascular smooth muscle commitment from human mesenchymal stem cells
Source abstract
Abstract
Mesenchymal stem cells (MSCs) hold great promise for vascular smooth muscle regeneration. However, most studies have mainly relied on extended supplementation of sophisticated biochemical regimen to drive MSC differentiation towards vascular smooth muscle cells (vSMCs). Herein we demonstrate a concomitant method that exploits the advantages of biomimetic matrix stiffness and tethered transforming growth factor β1 (TGF-β1) to guide vSMC commitment from human MSCs. Our designed poly(ethylene glycol) hydrogels, presenting a biomimetic stiffness and tethered TGF-β1, provide an instructive environment to potently upregulate smooth muscle marker expression in vitro and in vivo. Importantly, it significantly enhances the functional contractility of vSMCs derived from MSCs within 3 days. Interestingly, compared to non-tethered one, tethered TGF-β1 enhanced the potency of vSMC commitment on hydrogels. We provide compelling evidence that combining stiffness and tethered TGF-β1 on poly(ethylene glycol) hydrogels can be a promising approach to drastically enhance maturation and function of vSMCs from stem cell differentiation in vitro and in vivo. STATEMENT OF SIGNIFICANCE: A fast, reliable and safe regeneration of vascular smooth muscle cells (vSMCs) from stem cell differentiation is promising for vascular tissue engineering and regenerative medicine applications, but remains challenging. Herein, a photo-click hydrogel platform is devised to recapitulate the stiffness of vascular tissue and appropriate presentation of transforming growth factor β1 (TGF-β1) to guide vSMC commitment from mesenchymal stem cells (MSCs). We demonstrate that such concomitant method drastically enhanced regeneration of mature, functional vSMCs from MSCs in vitro and in vivo within only a 3-days span. This work is not only of fundamental scientific importance, revealing how physiochemical factors and the manner of their presentation direct stem cell differentiation, but also attacks the long-standing difficulty in regenerating highly functional vSMCs within a short period.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Hippo pathway signaling and YAP/TAZ · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders10.1124/pr.115.010652 ↗
2. The use of mesenchymal stem cells in tissue engineering: a global assessment10.4161/org.6048 ↗
3. Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro10.1007/s12015-010-9144-3 ↗
4. Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells10.1093/cvr/cvs315 ↗
5. Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering10.1016/j.biomaterials.2017.09.019 ↗
6. Harnessing developmental processes for vascular engineering and regeneration10.1242/dev.102194 ↗
7. Compliant substratum guides endothelial commitment from human pluripotent stem cells10.1126/sciadv.1602883 ↗
8. Biomimetic soft fibrous hydrogels for contractile and pharmacologically responsive smooth muscle10.1016/j.actbio.2018.05.015 ↗
9. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β10.1016/j.biomaterials.2011.02.019 ↗
10. Human mesenchymal stem cells cultured on silk hydrogels with variable stiffness and growth factor differentiate into mature smooth muscle cell phenotype10.1016/j.actbio.2015.11.051 ↗
11. “Dirty little secrets”—endotoxin contamination of recombinant proteins10.1016/j.imlet.2006.04.007 ↗
12. Sorescu · 2006
13. Multimodal release of transforming growth factor-β1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels10.1016/j.jconrel.2010.03.026 ↗
14. The synergistic effect of surface topography and sustained release of TGF‐β1 on myogenic differentiation of human mesenchymal stem cells10.1002/jbm.a.35686 ↗
15. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells10.1016/S0142-9612(00)00196-4 ↗
16. Covalently tethered TGF‐β1 with encapsulated chondrocytes in a peg hydrogel system enhances extracellular matrix production10.1002/jbm.a.35115 ↗
17. Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertension10.1172/jci.insight.86987 ↗
18. Implantable tissue-engineered blood vessels from human induced pluripotent stem cells10.1016/j.biomaterials.2016.06.010 ↗
19. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering10.1089/ten.teb.2009.0630 ↗
20. Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate10.1371/journal.pone.0088089 ↗
21. In-depth evaluation of commercially available human vascular smooth muscle cells phenotype: implications for vascular tissue engineering10.1016/j.yexcr.2016.04.004 ↗
22. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts10.1016/j.jtcvs.2011.06.046 ↗
23. Regenerative and durable small-diameter graft as an arterial conduit10.1073/pnas.1905966116 ↗
24. Smooth muscle contraction and relaxation10.1152/advances.2003.27.4.201 ↗
25. Role of YAP/TAZ in mechanotransduction10.1038/nature10137 ↗
26. Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP10.1101/gad.192856.112 ↗
27. Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway10.1073/pnas.1306369110 ↗
28. Dynamic stiffening of poly (ethylene glycol)-based hydrogels to direct valvular interstitial cell phenotype in a three-dimensional environment10.1016/j.biomaterials.2015.01.047 ↗
29. Long-term xeno-free culture of human pluripotent stem cells on hydrogels with optimal elasticity10.1038/srep18136 ↗
30. Combinational effect of matrix elasticity and alendronate density on differentiation of rat mesenchymal stem cells10.1016/j.actbio.2015.03.018 ↗
31. Physical cues of biomaterials guide stem cell fate of differentiation: the effect of elasticity of cell culture biomaterials10.1515/phys-2018-0116 ↗
32. Transforming growth factor β‐3 bound with sulfate polysaccharide in synthetic extracellular matrix enhanced the biological activities for neocartilage formation in vivo10.1002/jbm.a.32271 ↗
33. Materials as morphogenetic guides in tissue engineering10.1016/j.copbio.2003.09.004 ↗
34. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer10.1038/nrd2359 ↗
35. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction10.1016/j.yexcr.2015.10.034 ↗
36. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation10.1152/ajpcell.67.2008 ↗
37. Rigidity sensing and adaptation through regulation of integrin types10.1038/nmat3960 ↗
38. Investigating the interplay between substrate stiffness and ligand chemistry in directing mesenchymal stem cell differentiation within 3D macro-porous substrates10.1016/j.biomaterials.2018.04.026 ↗
39. Serum-free differentiation of functional human coronary-like vascular smooth muscle cells from embryonic stem cells10.1093/cvr/cvs357 ↗
40. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds10.1016/j.biomaterials.2014.07.011 ↗
41. Applying elastic fibre biology in vascular tissue engineering10.1098/rstb.2007.2134 ↗
42. Substantial expression of mature elastin in arterial constructs10.1073/pnas.1017834108 ↗
43. Tissue engineering of acellular vascular grafts capable of somatic growth in young lambs10.1038/ncomms12951 ↗
44. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells10.1016/j.actbio.2017.01.083 ↗
45. Vascular smooth muscle cell functional contractility depends on extracellular mechanical properties10.1016/j.jbiomech.2015.07.029 ↗
46. Regulating orientation and phenotype of primary vascular smooth muscle cells by biodegradable films patterned with arrays of microchannels and discontinuous microwalls10.1016/j.biomaterials.2010.04.059 ↗
47. The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor β1 in vascular smooth muscle cells10.1016/j.biomaterials.2010.08.105 ↗